Master
Heading
Vaccines
Content
- SARS-Cov-2 (Covid-19)
- A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2--Thimmaraju et al.--Vaccines
- From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access--Hotez et al. Expert Review of Vaccines
- MERS
- Characteristic profiling of CHO-cell expressed MERS-CoV RBD-Fc--Almutairi et al. International Journal of Biological Macromolecules
- SARS
- Tools
Media Component
Media
